Evaluating the prevalence of virulence genes of Escherichia coli in patients affected by urinary tract infection

سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 290

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

MEDISM20_288

تاریخ نمایه سازی: 26 بهمن 1398

چکیده مقاله:

Introduction and Objectives: Urinary tract infection due to Escherichia coli remains to be a major health problem worldwide. UPEC is one of the major causes of urinary tract infections among the general public. These bacteria have various virulence factors, including adhesion and toxins. Pilli P and FimA are the main members of E. coli adhesion in the pathogenesis of urinary tract infections. Due to high prevalence of urinary tract infections in the community, the aim of the present study was to evaluate the prevalence of fimA, hly-A and papG virulence genes in Uropathogenic Escherichia coli in Iranian female adults with urinary tract infections. Materials and Methods: From March to October 2016, 200 urine samples were collected from 200 inpatient and outpatient women. The Escherichia coli bacteria was detected and isolated, using biochemical techniques and supplementary tests in the Microbiology Laboratory of Shahrekord University of Medical Sciences. Then virulence factors were identified by PCR method. Result: The prevalence of papG, fimA and hlyA were 44, 74 and 26% of in inpatients and 52%, 76% and 28%, in outpatients, respectively. Conclusion: There was a significant correlation between papG and pyelonephritis in inpatients. There was no relationship between the frequency of papG, fimA and hlyA genes, and cystitis. The results of this study indicated that the fimA gene was the most frequent among the general public, and the hlyA gene was the least frequent and the papG gene was associated with pyelonephritis.

کلیدواژه ها:

نویسندگان

Farshad Kakian

Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Abolfazl Gholipour

Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.